Close

Isis Pharmaceuticals, Inc. (ISIS) Posts Q2 Loss of 9c/Share

August 6, 2013 8:32 AM EDT
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q2 EPS of ($0.09), $0.12 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $38.1 million versus the consensus estimate of $26.76 million.

For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings